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As reported by the American Cancer Society, lung and bronchus cancers have the highest death 
rate by far, compared to other types of cancer. The main reason is the lack of early stage non-
invasive screening methods. Indeed, the death rate of the other most abundant cancers, i.e. 
colorectum, prostate, and breast, is decreasing due to the implementation of large scale 
population screening techniques. It is believe that the death rate of lung cancer could be lowered 
by developing and implementing more efficient diagnostic methods 1. 
 
During the last couple of decades, a growing number of lung inspection procedures were 
developed based on breath analysis. These techniques are targeting the signature of the disease 
inside the volatile organic compounds (VOC) mixture exhaled by the patient 2. In the hope of 
developing a similar technology for cancer diagnostic, we used comprehensive two-dimensional 
gas chromatography coupled to high-resolution spectrometry (GC×GC-HRMS) to investigate 
the volatile profile of in vitro and in vivo samples. 
 
A procedure combining headspace sampling and GC×GC-HRMS was applied to cancer cell 
cultures and exhaled air samples from patients. The two screening were conducted in parallel in 
order to obtain independent sources of information. Both studies involved deep data processing 
techniques combining chromatogram alignment and robust statistics. A statistical separation 
was obtained between the control and the patient groups. Compounds responsible of this 
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